Comments on: bluebird bio Receives Positive Opinion from CHMP for ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia (TDT) Who Do Not Have β0/β0 Genotype

Comments on: bluebird bio Receives Positive Opinion from CHMP for ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia (TDT) Who Do Not Have β0/β0 Genotype https://www.novumpr.nl/2019/03/29/bluebird-bio-receives-positive-opinion-from-chmp-for-zynteglo-autologous-cd34-cells-encoding-%ce%b2a-t87q-globin-gene-gene-therapy-for-patients-12-years-and-older-with-transfusion-dependen/?utm_source=rss&utm_medium=rss&utm_campaign=bluebird-bio-receives-positive-opinion-from-chmp-for-zynteglo-autologous-cd34-cells-encoding-%25ce%25b2a-t87q-globin-gene-gene-therapy-for-patients-12-years-and-older-with-transfusion-dependen NovumPR press releases Fri, 29 Mar 2019 15:32:14 +0000 hourly 1 https://wordpress.org/?v=6.8.3